Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Carin Al Uyl-de Groot, PhD, Erasmus University Rotterdam, Rotterdam, The Netherlands, outlines the socioeconomic impact of CAR T-cell products, in particular, the pre- and post-CAR T-cell therapy costs. This interview took place at the 2nd European CAR T-Cell Meeting in Sitges, Spain.
We use necessary cookies to make this site work. Analytics, preference, and marketing cookies are used only if you choose to allow them. You can change your choice at any time. For more information view our Cookie Policy.